PL2878299T3 - Plaster adhezyjny - Google Patents
Plaster adhezyjnyInfo
- Publication number
- PL2878299T3 PL2878299T3 PL13822503T PL13822503T PL2878299T3 PL 2878299 T3 PL2878299 T3 PL 2878299T3 PL 13822503 T PL13822503 T PL 13822503T PL 13822503 T PL13822503 T PL 13822503T PL 2878299 T3 PL2878299 T3 PL 2878299T3
- Authority
- PL
- Poland
- Prior art keywords
- adhesive patch
- patch
- adhesive
- Prior art date
Links
- 239000000853 adhesive Substances 0.000 title 1
- 230000001070 adhesive effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012165793 | 2012-07-26 | ||
| JP2013078583 | 2013-04-04 | ||
| PCT/JP2013/070196 WO2014017594A1 (ja) | 2012-07-26 | 2013-07-25 | 貼付剤 |
| EP13822503.2A EP2878299B1 (en) | 2012-07-26 | 2013-07-25 | Adhesive patch |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2878299T3 true PL2878299T3 (pl) | 2018-10-31 |
Family
ID=49997402
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13823177T PL2878300T3 (pl) | 2012-07-26 | 2013-07-25 | Plaster |
| PL13822503T PL2878299T3 (pl) | 2012-07-26 | 2013-07-25 | Plaster adhezyjny |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13823177T PL2878300T3 (pl) | 2012-07-26 | 2013-07-25 | Plaster |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US9687474B2 (pl) |
| EP (3) | EP2878298B1 (pl) |
| JP (5) | JP6067707B2 (pl) |
| KR (3) | KR102013476B1 (pl) |
| CN (3) | CN104507472B (pl) |
| ES (3) | ES2633974T3 (pl) |
| PL (2) | PL2878300T3 (pl) |
| PT (2) | PT2878300T (pl) |
| TW (3) | TWI603748B (pl) |
| WO (3) | WO2014017593A1 (pl) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180360968A1 (en) * | 2012-07-26 | 2018-12-20 | Hisamitsu Pharmaceutical Co., Inc. | Patch |
| US11123305B2 (en) | 2012-07-26 | 2021-09-21 | Hisamitsu Pharmaceutical Co., Inc. | Patch |
| EP2878298B1 (en) * | 2012-07-26 | 2017-05-03 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch and production method therefor |
| US10493156B2 (en) | 2012-07-26 | 2019-12-03 | Hisamitsu Pharmaceutical Co., Inc. | Patch and method for producing the same |
| WO2015072494A1 (ja) * | 2013-11-12 | 2015-05-21 | 扶桑薬品工業株式会社 | 新規二酢酸ナトリウム結晶及び該結晶を含有する固形透析用製剤 |
| JP2016153391A (ja) * | 2015-02-16 | 2016-08-25 | 日本合成化学工業株式会社 | 無水酢酸ナトリウム結晶 |
| CN112843023A (zh) * | 2015-07-27 | 2021-05-28 | 久光制药株式会社 | 含有阿塞那平的贴剂的制造方法 |
| KR102005202B1 (ko) * | 2015-07-27 | 2019-07-29 | 히사미쓰 세이야꾸 가부시키가이샤 | 아세나핀 함유 첩부제 |
| EP3533777B1 (en) * | 2016-10-28 | 2023-07-26 | Tomita Pharmaceutical Co., Ltd. | Higher-order acetate compound, and solid dialysis agent using same |
| CA3047354A1 (en) | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
| RU2762896C2 (ru) * | 2016-12-20 | 2021-12-23 | Лтс Ломанн Терапи-Систем Аг | Трансдермальная терапевтическая система, содержащая азенапин |
| EP3644973B1 (en) * | 2017-06-26 | 2021-03-24 | LTS LOHMANN Therapie-Systeme AG | Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer |
| CN112533593A (zh) * | 2018-06-20 | 2021-03-19 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| CN110958876B (zh) | 2018-06-20 | 2020-12-18 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| JP7274834B2 (ja) * | 2018-08-10 | 2023-05-17 | 久光製薬株式会社 | アセナピン含有貼付剤 |
| CN112789039B (zh) | 2018-10-01 | 2023-10-24 | 久光制药株式会社 | 含有阿塞那平的贴剂 |
| CN113226308B (zh) | 2018-10-01 | 2024-12-10 | 久光制药株式会社 | 含有阿塞那平的贴剂 |
| JP2020141256A (ja) | 2019-02-28 | 2020-09-03 | ソニーセミコンダクタソリューションズ株式会社 | 復調回路、復調方法、送信装置 |
| CN110123793A (zh) * | 2019-06-03 | 2019-08-16 | 深圳市泛谷药业股份有限公司 | 一种阿塞那平或其盐的贴剂及其制备方法 |
| KR102883506B1 (ko) | 2019-10-28 | 2025-11-12 | 히사미쓰 세이야꾸 가부시키가이샤 | 아세나핀-n-옥사이드의 생성을 억제하는 방법 |
| US20210228496A1 (en) * | 2020-01-24 | 2021-07-29 | Hisamitsu Pharmaceutical Co., Inc. | Method for reducing skin sensitization of an asenapine-containing patch |
| US20230034383A1 (en) * | 2021-07-21 | 2023-02-02 | Hisamitsu Pharmaceutical Co., Inc. | Method for reducing skin sensitization of an asenapine-containing patch |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0747535B2 (ja) | 1985-11-26 | 1995-05-24 | 日東電工株式会社 | 消炎鎮痛用貼付剤 |
| JPH01207246A (ja) * | 1988-02-12 | 1989-08-21 | Nissan Chem Ind Ltd | 外用製剤用基剤組成物及び外用医薬組成物 |
| EP0387751B1 (en) | 1989-03-15 | 1994-06-08 | Nitto Denko Corporation | Medicated plasters |
| JP2933944B2 (ja) | 1989-03-29 | 1999-08-16 | 日東電工株式会社 | 医療用貼付剤 |
| JP2693212B2 (ja) | 1989-03-28 | 1997-12-24 | 日東電工株式会社 | 疾患治療用テープ製剤 |
| TW411277B (en) * | 1996-05-13 | 2000-11-11 | Hisamitsu Pharmaceutical Co | Percutaneous tape preparation containing fentanyl |
| JP3184474B2 (ja) * | 1997-03-10 | 2001-07-09 | ニチバン株式会社 | 経皮吸収製剤 |
| DE19814083C2 (de) | 1998-03-30 | 2002-02-07 | Lohmann Therapie Syst Lts | Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen |
| JP4205778B2 (ja) | 1998-04-17 | 2009-01-07 | 久光製薬株式会社 | 貼付製剤 |
| US6129929A (en) | 1998-10-30 | 2000-10-10 | Noven Pharmaceuticals, Inc. | Patch applicator |
| DE60045153D1 (de) | 1999-04-13 | 2010-12-09 | Hisamitsu Pharmaceutical Co | Zubereitungen zur perkutanen absorption |
| US20040142024A1 (en) | 1999-07-27 | 2004-07-22 | Hisamitsu Pharmaceutical Co., Inc. | Patch formulation for external use |
| DK1201232T3 (da) | 1999-07-27 | 2007-08-13 | Hisamitsu Pharmaceutical Co | Plastre til ydre anvendelse |
| US6586000B2 (en) * | 1999-12-16 | 2003-07-01 | Dermatrends, Inc. | Hydroxide-releasing agents as skin permeation enhancers |
| US6966990B2 (en) * | 2002-10-11 | 2005-11-22 | Ferro Corporation | Composite particles and method for preparing |
| US20080038328A1 (en) | 2004-05-28 | 2008-02-14 | Naruhito Higo | Pasting Preparation |
| EP1814531B1 (en) | 2004-10-21 | 2010-06-16 | Durect Corporation | Transdermal delivery systems |
| AR056306A1 (es) * | 2005-04-07 | 2007-10-03 | Organon Nv | FORMA CRISTALINA ORTORRoMBICA DEL MALEATO DE ASENAPINA , COMPOSICIONES FARMACÉUTICAS Y SU USO EN EL TRATAMIENTO DE TRASTORNOS MENTALES |
| WO2007077741A1 (ja) * | 2005-12-28 | 2007-07-12 | Hisamitsu Pharmaceutical Co., Inc. | 経皮吸収型製剤 |
| JP5181320B2 (ja) * | 2006-10-18 | 2013-04-10 | ニチバン株式会社 | 皮膚刺激の少ない経皮吸収型製剤 |
| ES2648197T3 (es) | 2008-02-27 | 2017-12-29 | Hisamitsu Pharmaceutical Co., Inc. | Parche medicado |
| WO2009110351A1 (ja) | 2008-03-03 | 2009-09-11 | 久光製薬株式会社 | 経皮吸収製剤 |
| JP5301190B2 (ja) * | 2008-03-31 | 2013-09-25 | 積水メディカル株式会社 | 貼付剤 |
| EP2299983A4 (en) | 2008-07-24 | 2012-10-10 | Handa Pharmaceuticals Llc | ATYPICAL ANTIPSYCHOTIC FORMULATION STABILIZED |
| WO2010119455A2 (en) | 2009-04-15 | 2010-10-21 | Sun Pharma Advanced Research Company Ltd. | An injectable sustained release pharmaceutical composition |
| WO2010127674A1 (en) | 2009-05-06 | 2010-11-11 | Sunin K/S | Transdermal compositions of asenapine for the treatment of psychiatric disorders |
| BRPI1011453A2 (pt) * | 2009-06-24 | 2016-03-15 | Msd Oss Bv | formulacao, forma de dosagem de um medicamento, e, sal de hemipamoato de asenapina |
| US20130053357A1 (en) * | 2010-04-28 | 2013-02-28 | Hisamitsu Pharmaceutical Co., Inc. | Skin irritation suppressant and transdermal preparation |
| WO2012066565A2 (en) * | 2010-11-16 | 2012-05-24 | Cadila Healthcare Limited | Asenapine maleate amorphous and crystalline form and process for preparation thereof |
| EP2878298B1 (en) * | 2012-07-26 | 2017-05-03 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch and production method therefor |
-
2013
- 2013-07-25 EP EP13822452.2A patent/EP2878298B1/en active Active
- 2013-07-25 JP JP2014527003A patent/JP6067707B2/ja active Active
- 2013-07-25 US US14/416,964 patent/US9687474B2/en active Active
- 2013-07-25 KR KR1020157003413A patent/KR102013476B1/ko active Active
- 2013-07-25 US US14/417,205 patent/US9511051B2/en active Active
- 2013-07-25 ES ES13822452.2T patent/ES2633974T3/es active Active
- 2013-07-25 ES ES13823177.4T patent/ES2632946T3/es active Active
- 2013-07-25 US US14/416,983 patent/US10022445B2/en active Active
- 2013-07-25 CN CN201380039627.1A patent/CN104507472B/zh active Active
- 2013-07-25 PL PL13823177T patent/PL2878300T3/pl unknown
- 2013-07-25 JP JP2014527004A patent/JP6005742B2/ja active Active
- 2013-07-25 KR KR1020157003414A patent/KR102013477B1/ko active Active
- 2013-07-25 TW TW102126723A patent/TWI603748B/zh active
- 2013-07-25 ES ES13822503.2T patent/ES2681034T3/es active Active
- 2013-07-25 CN CN201380039623.3A patent/CN104487072B/zh active Active
- 2013-07-25 WO PCT/JP2013/070195 patent/WO2014017593A1/ja not_active Ceased
- 2013-07-25 PT PT138231774T patent/PT2878300T/pt unknown
- 2013-07-25 KR KR1020157003415A patent/KR102013478B1/ko active Active
- 2013-07-25 EP EP13822503.2A patent/EP2878299B1/en active Active
- 2013-07-25 PL PL13822503T patent/PL2878299T3/pl unknown
- 2013-07-25 EP EP13823177.4A patent/EP2878300B1/en active Active
- 2013-07-25 CN CN201380036224.1A patent/CN104487071B/zh active Active
- 2013-07-25 WO PCT/JP2013/070196 patent/WO2014017594A1/ja not_active Ceased
- 2013-07-25 JP JP2014527002A patent/JP6005741B2/ja active Active
- 2013-07-25 PT PT138225032T patent/PT2878299T/pt unknown
- 2013-07-25 TW TW102126722A patent/TWI594771B/zh active
- 2013-07-25 TW TW102126721A patent/TWI592170B/zh active
- 2013-07-25 WO PCT/JP2013/070197 patent/WO2014017595A1/ja not_active Ceased
-
2016
- 2016-09-07 JP JP2016174418A patent/JP6272418B2/ja active Active
- 2016-10-24 US US15/331,939 patent/US10080738B2/en active Active
- 2016-11-08 JP JP2016217867A patent/JP6286011B2/ja active Active
-
2017
- 2017-03-09 US US15/454,066 patent/US10583121B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2878299T3 (pl) | Plaster adhezyjny | |
| EP2900135A4 (en) | IMPACT ADHESIVE PASTILLE | |
| DK2830816T3 (en) | Hidtil ukendt coatingkoncept | |
| DK3327112T3 (en) | Agse-deficient stamme | |
| SG11201404815YA (en) | Transdermal patch | |
| PT2807831T (pt) | Montagem de quadro de interligação | |
| EP2812944A4 (en) | SUPRALUMINIC ANTENNA | |
| SI2738232T1 (sl) | Lepilni sestavek | |
| EP2935220A4 (en) | PERI-carbinol | |
| PT2865378T (pt) | Adesivo para a pele | |
| PL2859892T3 (pl) | Plaster | |
| EP2933302A4 (en) | ADHESIVE COMPOSITION | |
| GB2506114B (en) | Boot | |
| EP2674467A4 (en) | aDHESIVE MASS | |
| EP2835868A4 (en) | ANTENNA | |
| EP2928018A4 (en) | ANTENNA | |
| GB2518574B (en) | Adhesive applicator | |
| PL2872583T3 (pl) | Układ adhezyjny | |
| EP2893927A4 (en) | SKIN PATCH | |
| EP2752188A4 (en) | TRANSDERMAL STAMP | |
| EP2939705A4 (en) | IONTOPHORESIS PASTILLE | |
| PL2895125T3 (pl) | Opatrunek samoprzylepny | |
| GB2504561B (en) | Patch antenna | |
| GB201221038D0 (en) | Antenna | |
| GB201213709D0 (en) | Patch |